Rethinking the Gene Patent Article

One of the most popular podcasts in the Health Thought Leadership series, here is the link to Alan Morrison’s article as a PDF, Rethinking the Gene Patent, published in the Biotechnology Law Report. The article accompanies the November 2010 post and podcast on the Myriad decision rendered by the U.S. District Court for the Southern District of New York.

Read why Alan reasons that “the court did not properly apply existing law. Instead it relied on what appears to be a new and problematic doctrine excluding isolated DNA from the realm of patent-eligible subject material.”

Leave a Reply